alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › glp1

glp1

2 studies tagged glp1, dated 2019-01-11 to 2020-08-11. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Repurposing GLP1 agonists for neurodegenerative diseases 2020-08-11
  2. Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer's Disease 2019-01-11

Studies

2 studies carry this tag.

Date range

2019 to 2020

Top journals

  • International review of neurobiology 1
  • Journal of molecular neuroscience : MN 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Repurposing GLP1 agonists for neurodegenerative diseases

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. International review of neurobiology 2020-08-11 Drug development

    There is a large unmet medical need to find disease modifying therapies against neurodegenerative diseases.

  2. Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of molecular neuroscience : MN 2019-01-11 Drug development

    Disruption of brain insulin signaling may explain the higher Alzheimer's disease (AD) risk among type 2 diabetic (T2D) patients.

All topic tags with their study counts